| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 629,393 | 624,170 | 1,079,975 | 926,193 | | Cost of Revenue | 277,669 | 443,211 | 1,059,783 | 414,552 | | | Gross Profit | 351,724 | 180,959 | 20,192 | 511,641 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 248,126 | 43,600 | (352,289) | 234,982 | | Non Recurring | 211,306 | 53,250 |
-
|
-
| | Others | 99,921 | 98,399 | 98,568 | 97,784 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (207,629) | (14,290) | 273,913 | 178,875 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,369) | (5,020) | (185) | (721) | | Earnings Before Interest And Taxes | (211,998) | (19,310) | 273,728 | 178,154 | | Interest Expense | 51,972 | 54,483 | 47,255 | 46,645 | | Income Before Tax | (263,970) | (73,793) | 226,473 | 131,509 | | Income Tax Expense | (96,174) | (27,082) | 75,970 | 17,076 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (167,796) | (46,711) | 150,503 | 114,433 | | | Non-recurring Events | | Discontinued Operations | (2,924) | 7,861 | 1,083 | 19,429 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (170,720) | (38,850) | 151,586 | 133,862 | | Preferred Stock And Other Adjustments | 14,210 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($156,510) | ($38,850) | $151,586 | $133,862 |
|
0.45% Nasdaq 
0.20%
Income Statement
